Datavant Completes Acquisition of Aetion, Enhancing Healthcare Data Platform
Datavant, a leading health data platform company based in Phoenix, AZ, has finalized the acquisition of Aetion, a prominent real-world evidence (RWE) platform utilized in healthcare decision-making.
The specific financial details of the acquisition have not been disclosed to the public.
With Aetion now integrated into Datavant’s Life Sciences division, the company is poised to offer a comprehensive platform for data feasibility and analysis. This development will enable healthcare and life sciences organizations to efficiently address research inquiries regarding the clinical impact of therapies in development and on the market.
Aetion’s Role in Transforming Healthcare Decision-Making
Aetion, a global healthcare technology company, specializes in providing RWE solutions to various stakeholders in the healthcare industry. By leveraging advanced causal inference, robust epidemiologic methods, and purpose-built AI, Aetion transforms complex healthcare data into transparent and reliable evidence on the safety, efficacy, and value of medical treatments.
This evidence-based approach informs crucial healthcare decisions, such as identifying the most effective treatments for specific patient populations. Additionally, Aetion’s solutions support regulatory submissions, market access strategies, and clinical development efforts.
Datavant’s Commitment to Secure and Actionable Health Data
Under the leadership of CEO Kyle Armbrester, Datavant has established itself as a key player in the health data space. The company facilitates the secure and seamless exchange of over 60 million healthcare records among thousands of organizations, including hospitals, clinics, and health systems.
Through its extensive network of data partners, Datavant empowers healthcare and life sciences entities to access actionable insights for informed decision-making.
Overall, the acquisition of Aetion represents a significant milestone for Datavant, further solidifying its position as a leader in the healthcare data platform industry.
Published by FinSMEs on 12/07/2025
